Zhejiang
300357.SZZhejiang Wolwo Bio-Pharmaceutical Co., Ltd. Price (300357.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
523,607,157
(0.0044)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.Currency: CNY
| YEAR | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
37,407,159.00
+0% |
59,327,652.00
+59% |
103,176,299.00
+74% |
147,517,280.00
+43% |
193,609,754.00
+31% |
239,511,105.00
+24% |
267,105,585.00
+12% |
312,085,773.00
+17% |
385,576,841.00
+24% |
500,744,692.00
+30% |
639,352,853.00
+28% |
636,208,242.00
0% |
807,691,606.00
+27% |
896,016,141.00
+11% |
848,190,443.00
-5% |
||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 4,528,889.00 | 5,689,320.00 | 6,472,295.00 | 7,559,063.00 | 7,374,316.00 | 9,732,462.00 | 13,104,036.00 | 11,555,335.00 | 14,085,609.00 | 28,518,185.00 | 22,852,631.00 | 28,537,268.00 | 34,437,972.00 | 41,277,575.00 | 40,189,443.00 | ||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
32,878,270.00
+0% |
53,638,332.00
+63% |
96,704,004.00
+80% |
139,958,217.00
+45% |
186,235,438.00
+33% |
229,778,643.00
+23% |
254,001,549.00
+11% |
300,530,438.00
+18% |
371,491,232.00
+24% |
472,226,507.00
+27% |
616,500,222.00
+31% |
607,670,974.00
-1% |
773,253,634.00
+27% |
854,738,566.00
+11% |
808,001,000.00
-5% |
||||
| Gross Profit Ratio | (0.88%) | (0.90%) | (0.94%) | (0.95%) | (0.96%) | (0.96%) | (0.95%) | (0.96%) | (0.96%) | (0.94%) | (0.96%) | (0.96%) | (0.96%) | (0.95%) | (0.95%) | ||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 0.00 | 3,924,043.00 | 3,818,005.00 | 5,770,732.00 | 10,088,094.00 | 10,996,914.00 | 10,300,721.00 | 9,237,397.00 | 7,701,704.00 | 13,478,608.00 | 41,171,088.00 | 64,874,787.00 | 87,926,685.00 | 106,019,343.00 | 96,324,172.00 | ||||
| General and Administrative | 7,426,953.00 | 3,841,380.00 | 5,547,266.00 | 7,697,619.00 | 4,663,079.00 | 10,469,855.00 | 5,277,366.00 | 5,557,260.00 | 8,608,687.00 | 8,840,138.00 | 8,135,913.00 | 7,500,740.00 | 8,684,342.00 | 5,575,259.00 | 9,264,044.00 | ||||
| Selling, General & Admin... | 25,859,271.00 | 27,162,539.00 | 43,345,980.00 | 63,631,243.00 | 80,389,535.00 | 99,160,620.00 | 101,321,823.00 | 120,053,936.00 | 137,496,535.00 | 177,128,392.00 | 231,838,179.00 | 231,155,616.00 | 290,792,655.00 | 317,386,052.00 | 332,431,173.00 | ||||
| Selling & Marketing Exp... | 18,432,318.00 | 23,321,159.00 | 37,798,713.00 | 55,933,623.00 | 75,726,456.00 | 88,690,764.00 | 96,044,457.00 | 114,496,675.00 | 128,887,847.00 | 168,288,254.00 | 223,702,265.00 | 223,654,875.00 | 282,108,312.00 | 311,810,793.00 | 323,167,128.00 | ||||
| Depreciation and Amortiz... | 2,175,700.00 | 2,571,654.00 | 3,209,002.00 | 3,293,873.00 | 3,626,265.00 | 3,943,314.00 | 4,160,791.00 | 6,213,695.00 | 6,522,120.00 | 7,357,825.00 | 10,845,694.00 | 16,459,387.00 | 27,018,983.00 | 28,015,103.00 | 39,407,460.00 | ||||
| Other Expenses | 28,326.00 | 2,069,993.00 | 2,759,973.00 | 3,045,045.00 | 1,460,284.00 | 6,511,864.00 | 4,529,095.00 | 371,860.00 | 2,746,497.00 | 1,626,657.00 | 25,185,908.00 | 16,934,787.00 | 28,472,242.00 | 16,078,581.00 | 34,272,302.00 | ||||
| Total Operating Expenses | 25,941,113.00 | 35,744,761.00 | 54,338,515.00 | 78,765,317.00 | 104,386,676.00 | 121,961,603.00 | 125,316,026.00 | 150,536,873.00 | 164,451,897.00 | 218,648,352.00 | 298,195,177.00 | 312,965,191.00 | 407,191,583.00 | 439,483,977.00 | 463,027,647.00 | ||||
| Cost and Exponses | 30,470,002.00 | 41,434,081.00 | 60,810,810.00 | 86,324,381.00 | 111,760,993.00 | 131,694,066.00 | 138,420,063.00 | 162,092,209.00 | 178,537,507.00 | 247,166,537.00 | 321,047,808.00 | 341,502,459.00 | 441,629,556.00 | 480,761,553.00 | 503,217,090.00 | ||||
| Operating Income | |||||||||||||||||||
| Operating Income |
9,778,859.00
+0% |
18,636,470.00
+91% |
41,174,581.00
+121% |
60,359,777.00
+47% |
81,691,790.00
+35% |
112,410,351.00
+38% |
134,122,564.00
+19% |
155,965,903.00
+16% |
216,222,729.00
+39% |
271,355,592.00
+25% |
343,374,907.00
+27% |
321,518,297.00
-6% |
392,905,337.00
+22% |
396,206,958.00
+1% |
344,973,353.00
-13% |
||||
| Operating Income Ratio | (0.26%) | (0.31%) | (0.40%) | (0.41%) | (0.42%) | (0.47%) | (0.50%) | (0.50%) | (0.56%) | (0.54%) | (0.54%) | (0.51%) | (0.49%) | (0.44%) | (0.41%) | ||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 0.00 | 697,506.00 | 275,700.00 | 509,322.00 | 942,963.00 | 4,479,608.00 | 5,295,071.00 | 4,478,115.00 | 3,893,006.00 | 11,268,263.00 | 24,153,039.00 | 23,306,489.00 | 22,641,864.00 | 24,774,074.00 | 30,957,179.00 | ||||
| Interest Expenses | 0.00 | 16,984.00 | 540,555.00 | 320,250.00 | 68,150.00 | 92,739.00 | 95,686.00 | 4,377,579.00 | 3,771,404.00 | 11,178,336.00 | 88,399.00 | 99,799.00 | 362,215.00 | 443,982.00 | 1,477,139.00 | ||||
| Total Other Income/Exp... | 26,523.00 | 2,049,922.00 | 2,759,392.00 | 3,042,890.00 | 1,419,137.00 | 6,467,801.00 | 4,493,631.00 | 371,861.00 | 2,746,497.00 | 1,626,657.00 | 2,341,275.00 | 1,097,888.00 | 92,307.00 | 2,540,336.00 | 982,152.00 | ||||
| EBITDA | |||||||||||||||||||
| EBITDA | 9,112,856.00 | 27,312,446.00 | 53,332,880.00 | 73,187,359.00 | 86,737,189.00 | 110,718,457.00 | 132,846,313.00 | 155,696,119.00 | 225,491,347.00 | 260,830,638.00 | 328,669,558.00 | 339,175,372.00 | 422,413,458.00 | 425,270,739.00 | 391,093,703.00 | ||||
| EBITDA ratio | (0.23%) | (0.40%) | (0.47%) | (0.46%) | (0.45%) | (0.47%) | (0.50%) | (0.52%) | (0.56%) | (0.52%) | (0.52%) | (0.48%) | (0.52%) | (0.53%) | (0.46%) | ||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 9,805,382.00 | 20,686,392.00 | 43,933,973.00 | 63,402,667.00 | 83,110,927.00 | 118,878,152.00 | 138,616,195.00 | 151,832,120.00 | 218,969,226.00 | 272,982,249.00 | 345,716,182.00 | 322,616,185.00 | 392,997,641.00 | 398,747,288.00 | 345,955,505.00 | ||||
| Income Before Tax Ratio | (0.26%) | (0.35%) | (0.43%) | (0.43%) | (0.43%) | (0.50%) | (0.52%) | (0.49%) | (0.57%) | (0.55%) | (0.54%) | (0.51%) | (0.49%) | (0.45%) | (0.41%) | ||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -707,811.36 | 2,280,512.00 | 6,669,244.00 | 9,633,453.00 | 12,559,815.00 | 19,329,507.00 | 20,799,622.00 | 22,631,145.00 | 32,865,280.00 | 41,118,010.00 | 53,095,990.00 | 52,891,852.00 | 66,708,885.00 | 63,022,274.00 | 50,433,428.00 | ||||
| Net Income | |||||||||||||||||||
| Net Income | 10,513,193.00
+0% |
18,405,879.00
+75% |
37,264,729.00
+102% |
53,773,772.00
+44% |
70,564,349.00
+31% |
99,554,760.00
+41% |
117,820,024.00
+18% |
129,200,974.00
+10% |
186,103,945.00
+44% |
232,884,097.00
+25% |
298,296,581.00
+28% |
278,447,284.00
-7% |
337,991,284.00
+21% |
348,773,471.00
+3% |
310,184,878.00
-11% |
||||
| Net Income Ratio | (0.28%) | (0.31%) | (0.36%) | (0.36%) | (0.36%) | (0.42%) | (0.44%) | (0.41%) | (0.48%) | (0.47%) | (0.47%) | (0.44%) | (0.42%) | (0.39%) | (0.37%) | ||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.02 | 0.04 | 0.08 | 0.12 | 0.15 | 0.19 | 0.23 | 0.25 | 0.36 | 0.44 | 0.57 | 0.53 | 0.65 | 0.67 | 0.59 | ||||
| Diluted EPS | 0.02 | 0.04 | 0.08 | 0.12 | 0.15 | 0.19 | 0.23 | 0.25 | 0.36 | 0.44 | 0.57 | 0.53 | 0.65 | 0.67 | 0.59 | ||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 471,171,601.00 | 471,171,601.00 | 471,171,601.00 | 464,605,391.00 | 466,588,759.00 | 520,139,817.00 | 522,927,232.00 | 523,263,947.00 | 523,580,965.00 | 523,570,363.00 | 523,583,999.00 | 523,583,999.00 | 523,583,999.00 | 523,583,999.00 | 523,607,157.00 | ||||
| Diluted Share Outstanding | 471,171,601.00 | 471,171,601.00 | 471,171,601.00 | 464,605,391.00 | 466,588,759.00 | 520,253,908.00 | 522,927,232.00 | 523,263,947.00 | 523,580,965.00 | 523,570,363.00 | 523,583,999.00 | 523,583,999.00 | 523,583,999.00 | 523,583,999.00 | 523,607,157.00 | ||||